Retina (Philadelphia, Pa.)

• 

  Publication Venue For

  • EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Subgroup Analyses From the VIEW Trials..  39:537-547. 2019
  • LONGITUDINAL CHANGES IN THE OPTIC NERVE HEAD AND RETINA OVER TIME IN VERY YOUNG CHILDREN WITH FAMILIAL EXUDATIVE VITREORETINOPATHY..  39:98-110. 2019
  • PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial..  39:69-78. 2019
  • CORRELATION OF GENE EXPRESSION PROFILE STATUS AND AMERICAN JOINT COMMISSION ON CANCER STAGE IN UVEAL MELANOMA. 2018
  • Diagnostic and Therapeutic Challenges..  38:2260-2266. 2018
  • CHOROIDAL TUMOR BIOPSY: A Review of the Current State and a Glance Into Future Techniques..  38 Suppl 1:S79-S87. 2018
  • COMBINED AUTOLOGOUS TRANSPLANTATION OF NEUROSENSORY RETINA, RETINAL PIGMENT EPITHELIUM, AND CHOROID FREE GRAFTS..  38 Suppl 1:S12-S22. 2018
  • COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY..  38:1675-1687. 2018
  • DUKE ADVANCED VITREOUS SURGERY COURSE AND THE DUKE FELLOWS ADVANCED VITREOUS SURGERY COURSE..  38 Suppl 1:S1. 2018
  • Diagnostic and Therapeutic Challenges..  38:1873-1875. 2018
  • SUBRETINAL TRANSPLANTATION OF AN AUTOLOGOUS RETINAL FREE FLAP FOR CHRONIC RETINAL DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY WITH AND WITHOUT MACULAR HOLE..  38 Suppl 1:S121-S124. 2018
  • VISUALIZATION FROM INTRAOPERATIVE SWEPT-SOURCE MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY IN VITRECTOMY FOR COMPLICATIONS OF PROLIFERATIVE DIABETIC RETINOPATHY..  38 Suppl 1:S110-S120. 2018
  • CENTRAL RETINAL VEIN OCCLUSION IN YOUNG INDIVIDUALS: A Comparison of Risk Factors and Clinical Outcomes. 2018
  • HANDHELD SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING THROUGH THE UNDILATED PUPIL IN INFANTS BORN PRETERM OR WITH HYPOXIC INJURY OR HYDROCEPHALUS..  38:1588-1594. 2018
  • CHARACTERIZATION OF THE CHOROIDAL VASCULATURE IN MYOPIC MACULOPATHY WITH OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY. 2018
  • RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study. 2018
  • USE OF THE ISCHEMIC INDEX ON WIDEFIELD FLUORESCEIN ANGIOGRAPHY TO CHARACTERIZE A CENTRAL RETINAL VEIN OCCLUSION AS ISCHEMIC OR NONISCHEMIC. 2018
  • EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT Results of the OASIS Trial ERG Substudy.  38:364-378. 2018
  • EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy..  38:364-378. 2018
  • MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.  38:211-219. 2018
  • MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA..  38:211-219. 2018
  • DETAILED CHARACTERIZATION OF CHOROIDAL MORPHOLOGIC AND VASCULAR FEATURES IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY..  37:2269-2280. 2017
  • OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEA IN CHILDREN BORN PRETERM..  37:2289-2294. 2017
  • STARGARDT DISEASE: Beyond Flecks and Atrophy..  37:2352-2361. 2017
  • ASSESSMENT OF THE RETINAL STRUCTURE IN CHILDREN WITH INCONTINENTIA PIGMENTI.  37:1568-1574. 2017
  • ASSESSMENT OF THE RETINAL STRUCTURE IN CHILDREN WITH INCONTINENTIA PIGMENTI..  37:1568-1574. 2017
  • CHARACTERIZATION AND DIFFERENTIATION OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY..  37:1464-1474. 2017
  • Correspondence..  37:e52-e54. 2017
  • Intraoperative 4-Dimensional Microscope-Integrated Optical Coherence Tomography-Guided 27-Gauge Transvitreal Choroidal Biopsy for Choroidal Melanoma..  37:796-799. 2017
  • AMBULATORY BLOOD PRESSURE PATTERNS IN PATIENTS WITH RETINAL VEIN OCCLUSION..  36:2304-2310. 2016
  • DYNAMIC CHANGES OF THE ANTERIOR CHAMBER ANGLE PRODUCED BY INTRAVITREAL ANTI-VASCULAR GROWTH FACTOR INJECTIONS..  36:1874-1881. 2016
  • VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION..  36:1021-1031. 2016
  • MYOPIC RETINOSCHISIS IN ASIANS: Structural Features and Determinants of Visual Acuity and Prognostic Factors for Progression..  36:717-726. 2016
  • SMALL-GAUGE VALVED VERSUS NONVALVED CANNULA PARS PLANA VITRECTOMY FOR RETINAL DETACHMENT REPAIR..  36:744-749. 2016
  • Correspondence..  36:e22-e23. 2016
  • FUNCTIONAL OUTCOMES OF YOUNG INFANTS WITH AND WITHOUT MACULAR EDEMA..  35:2018-2027. 2015
  • EPITHELIAL DOWNGROWTH IN THE VITREOUS CAVITY AND ON THE RETINA IN ENUCLEATED SPECIMENS AND IN EYES WITH VISUAL POTENTIAL..  35:1688-1695. 2015
  • INTRAOPERATIVE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IMAGING AFTER INTERNAL LIMITING MEMBRANE PEELING IN IDIOPATHIC EPIRETINAL MEMBRANE WITH CONNECTING STRANDS..  35:1622-1630. 2015
  • THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY: Retrospective Study and Systematic Review..  35:1577-1593. 2015
  • IDENTIFICATION OF FLUID ON OPTICAL COHERENCE TOMOGRAPHY BY TREATING OPHTHALMOLOGISTS VERSUS A READING CENTER IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS..  35:1303-1314. 2015
  • IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA..  35:1375-1380. 2015
  • Re: Impact of Macula-off Retinal Detachment on Visual Outcome, A Systematic Review and Meta-Analysis of Literature..  35:e44. 2015
  • Re: Pachychoroid neovasculopathy..  35:e39-e40. 2015
  • Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole..  35:1151-1157. 2015
  • SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION: A Comprehensive Analysis of Premarketing and Postmarketing Experiences..  35:1128-1134. 2015
  • Diagnostic and therapeutic challenges..  35:829-833. 2015
  • Metabolic syndrome and risk of age-related macular degeneration..  35:459-466. 2015
  • Simple surgeon-controlled method of safe, cost-effective, and efficient application of chromovitrectomy agents through reflux..  35:371-373. 2015
  • To the editor.  35:e39-e40. 2015
  • Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy..  34:2397-2406. 2014
  • Direct medical costs and resource use for treating central and branch retinal vein occlusion in commercially insured working-age and Medicare populations..  34:2250-2258. 2014
  • Spontaneous peripheral migration of subfoveal perfluorocarbon..  34:2315-2316. 2014
  • Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration..  34:1779-1786. 2014
  • Diagnostic and therapeutic challenges 2014
  • Associations between cardiovascular risk factors and early age-related macular degeneration in a rural Chinese adult population..  34:1539-1553. 2014
  • Diagnostic and therapeutic challenges..  34:1710-1712. 2014
  • Spectral domain optical coherence tomography characterization of pediatric epiretinal membranes..  34:1323-1334. 2014
  • Cost of phacovitrectomy versus vitrectomy and sequential phacoemulsification..  34:1112-1115. 2014
  • Diagnostic and therapeutic challenges..  34:1247-1252. 2014
  • Autoimmune retinopathy and antiretinal antibodies: a review..  34:827-845. 2014
  • Acute retinal pigment epithelium detachments after photocoagulation..  34:749-760. 2014
  • Diagnostic and therapeutic challenges..  34:816-820. 2014
  • Diagnostic and therapeutic challenges..  34:618-624. 2014
  • Acute retinal pigment epithelium detachments after photocoagulation.  34:749-760. 2014
  • Diagnostic and therapeutic challenges.  34:1710-1712. 2014
  • Spectral domain optical coherence tomography characterization of pediatric epiretinal membranes.  34:1323-1334. 2014
  • Spontaneous peripheral migration of subfoveal perfluorocarbon.  34:2315-2316. 2014
  • Localized changes in retinal vessel caliber after focal/grid laser treatment in patients with diabetic macular edema: a measure of treatment response?.  33:2089-2095. 2013
  • Spectral domain optical coherence tomography-determined morphologic predictors of age-related macular degeneration-associated geographic atrophy progression..  33:1590-1599. 2013
  • Preclinical evaluation and intraoperative human retinal imaging with a high-resolution microscope-integrated spectral domain optical coherence tomography device..  33:1328-1337. 2013
  • Reply: To PMID 22653543..  33:1481. 2013
  • Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries..  33:911-919. 2013
  • Costs of newly diagnosed neovascular age-related macular degeneration among medicare beneficiaries, 2004-2008..  33:854-861. 2013
  • Costs of newly diagnosed neovascular age-related macular degeneration among medicare beneficiaries, 2004-2008.  33:854-861. 2013
  • Preclinical evaluation and intraoperative human retinal imaging with a high-resolution microscope-integrated spectral domain optical coherence tomography device.  33:1328-1337. 2013
  • Spectral domain optical coherence tomography-determined morphologic predictors of age-related macular degeneration-associated geographic atrophy progression.  33:1590-1599. 2013
  • Ten-year incidence of age-related macular degeneration according to diabetic retinopathy classification among medicare beneficiaries.  33:911-919. 2013
  • Visualization of real-time intraoperative maneuvers with a microscope-mounted spectral domain optical coherence tomography system.  33:232-236. 2013
  • Comparison of color fundus photographs and fundus autofluorescence images in measuring geographic atrophy area..  32:1884-1891. 2012
  • Peripheral retinal vascular leakage demonstrated by ultra-widefield fluorescein angiography in preeclampsia with HELLP syndrome..  32:1689-1690. 2012
  • Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study..  32:1601-1607. 2012
  • The ARMS2 A69S variant and bilateral advanced age-related macular degeneration..  32:1486-1491. 2012
  • Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion..  31:1856-1862. 2011
  • Recovery of the neurosensory retina after macular translocation surgery is independent of preoperative macular sensitivity in neovascular age-related macular degeneration..  31:1637-1649. 2011
  • Treatment of non-age-related macular degeneration submacular diseases with macular translocation surgery..  31:1337-1346. 2011
  • Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation..  31:1009-1027. 2011
  • Preretinal and intraretinal exudates in familial exudative vitreoretinopathy..  31:190-191. 2011
  • Use of fundus autofluorescence images to predict geographic atrophy progression..  31:81-86. 2011
  • Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial..  30:1627-1637. 2010
  • Intraocular pressure instability after 23-gauge vitrectomy..  30:629-634. 2010
  • A pilot study using ROPtool to measure retinal vascular dilation..  29:1182-1187. 2009
  • Intravitreal injection of therapeutic agents..  29:875-912. 2009
  • Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema..  29:613-617. 2009
  • Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables..  29:300-305. 2009
  • Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006..  29:207-213. 2009
  • Central and pericentral retinal sensitivity after macular translocation surgery..  28:1522-1529. 2008
  • Computer-assisted assessment of plus disease in retinopathy of prematurity using video indirect ophthalmoscopy images..  28:1458-1462. 2008
  • Autofluorescence of choroidal nevus in 64 cases..  28:1035-1043. 2008
  • RECURRENT CHOROIDAL NEOVASCULARIZATION AFTER MACULAR TRANSLOCATION SURGERY WITH 360-DEGREE PERIPHERAL RETINECTOMY.  28:1221-1227. 2008
  • Recurrent choroidal neovascularization after macular translocation surgery with 360-degree peripheral retinectomy..  28:1221-1227. 2008
  • Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status..  28:1289-1295. 2008
  • The role of vitrectomy surgery in diabetic macular edema..  28:1366. 2008
  • A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features..  28:919-930. 2008
  • Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma..  28:987-995. 2008
  • Optical coherence tomography of optic disk melanocytoma in 15 cases..  28:441-446. 2008
  • Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies..  28:298-308. 2008
  • Early macular morphological changes following plaque radiotherapy for uveal melanoma..  28:263-273. 2008
  • Surgical drainage of chronic serous retinal detachment associated with uveitis..  28:282-288. 2008
  • Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema..  28:36-40. 2008
  • CENTRAL AND PERICENTRAL RETINAL SENSITIVITY AFTER MACULAR TRANSLOCATION SURGERY.  28:1522-1529. 2008
  • Autofluorescence of orange pigment overlying small choroidal melanoma..  27:1107-1111. 2007
  • Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion..  27:1020-1025. 2007
  • Natural history of foveolar lucencies observed by optical coherence tomography after macular hole surgery..  27:95-100. 2007
  • A method to free retina and vitreous from intraoperative incarceration in the sclerotomy..  26:1070-1071. 2006
  • Acute lymphoblastic leukemia presenting as bilateral serous macular detachments..  26:710-712. 2006
  • Macular degeneration: the latest in current surgical management..  26:S21-S25. 2006
  • Intravitreal triamcinolone acetonide for acute radiation papillopathy..  26:537-544. 2006
  • Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation..  26:285-291. 2006
  • Central retinal vein occlusion in patients on long term Coumadin anticoagulation.  26:285-291. 2006
  • Intravitreal triamcinolone acetonide for radiation maculopathy after plaque radiotherapy for choroidal melanoma..  25:868-874. 2005
  • Retinal racemose hemangioma..  25:936-937. 2005
  • Combined central retinal vein and artery occlusion associated with an isolated superior ophthalmic vein thrombosis..  25:805. 2005
  • Impact of fluorescein angiographic characteristics of macular lesions on outcomes after macular translocation 360 degree surgery in eyes with age-related macular degeneration..  25:597-607. 2005
  • Optical coherence tomography of choroidal nevus in 120 patients..  25:243-252. 2005
  • Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole..  24:275-282. 2004
  • Optical coherence tomography of congenital simple hamartoma of the retinal pigment epithelium..  24:327-328. 2004
  • The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment..  24:199-209. 2004
  • Transplantation of full-thickness retina in the rhodopsin transgenic pig..  24:98-109. 2004
  • Recovery of visual function after removal of chronic subfoveal perfluorocarbon liquid..  23:868-870. 2003
  • Dislocated ganciclovir implant from use of a nylon fixation suture..  23:723-724. 2003
  • The effect of intraoperative retinal manipulation on the underlying retinal pigment epithelium: an experimental study..  23:475-480. 2003
  • Transpupillary thermotherapy threshold parameters: effect of indocyanine green pretreatment..  23:378-386. 2003
  • Transpupillary thermotherapy threshold parameters: funduscopic, angiographic, and histologic findings in pigmented and nonpigmented rabbits..  23:371-377. 2003
  • The role of scleral buckle in experimental posterior penetrating eye injury..  23:202-208. 2003
  • Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study..  23:8-13. 2003
  • Modified external needle drainage procedure for rhegmatogenous retinal detachment..  23:80-85. 2003
  • New techniques for hemostasis during diabetic vitrectomy..  23:120-122. 2003
  • Combined hamartoma of the retina and retinal pigment epithelium: optical coherence tomography..  22:98-101. 2002
  • Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs..  21:324-331. 2001
  • Eye pain after vitreoretinal surgery: a prospective study of 185 patients..  21:627-632. 2001
  • Ischemic central retinal vein occlusion and retinitis pigmentosa: lower risk of neovascularization?.  21:179-180. 2001
  • Macular translocation with 360-degree peripheral retinectomy impact of technique and surgical experience on visual outcomes..  21:293-303. 2001
  • Management of eyes with both idiopathic macular hole and choroidal neovascularization..  21:613-618. 2001
  • Pharmacokinetics of the ganciclovir implant in the silicone-filled eye..  21:10-14. 2001
  • Successful macular translocation with temporary scleral infolding using absorbable sture..  21:304-311. 2001
  • Dexamethasone sustained drug delivery implant for the treatment of severe uveitis..  20:402-403. 2000
  • Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography..  20:115-120. 2000
  • Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema..  20:63-68. 2000
  • Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis..  20:190-194. 2000
  • Features of macular hole closure in the early postoperative period using optical coherence tomography..  20:232-237. 2000
  • Pharmacokinetics of the fluocinolone/5-fluorouracil codrug in the gas-filled eye..  20:514-519. 2000
  • Posttraumatic endophthalmitis due to CDC coryneform group A-3 bacteria..  20:412-413. 2000
  • Vitrectomy update for macular traction in ocular toxocariasis..  20:80-85. 2000
  • CORNEAL EPITHELIAL DEFECTS FOLLOWING VITRECTOMY SURGERY USING HAND-HELD, SEW-ON, AND NONCONTACT VIEWING LENSES.  19:287-287. 1999
  • CORNEAL EPITHELIAL DEFECTS FOLLOWING VITRECTOMY SURGERY USING HAND-HELD, SEW-ON, AND NONCONTACT VIEWING LENSES.  19:287-290. 1999
  • Diagnostic and therapeutic challenges..  19:336-341. 1999
  • A comparison of self-reported utilization of ophthalmic care for diabetes in managed care versus fee-for-service..  18:356-359. 1998
  • A tribute to Robert Machemer, MD, on the occasion of his retirement..  18:202-294. 1998
  • Arterial vascular occlusion associated with factor V Leiden gene mutation..  18:376-377. 1998
  • Conformance with the preferred practice pattern for diabetic eye care..  18:160-163. 1998
  • Spontaneous retinal reattachment in incontinentia pigmenti..  18:75-77. 1998
  • Front and side fiberoptic illuminator for vitreous surgery..  17:360. 1997
  • Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin..  17:315-320. 1997
  • Spontaneous giant retinal pigment epithelial tear associated with panuveitis..  17:254-256. 1997
  • Subretinal hemorrhages in proliferative diabetic retinopathy..  17:87-93. 1997
  • Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis..  17:94-98. 1997
  • Therapeutic effect of periocular corticosteroids in experimental proliferative vitreoretinopathy..  17:44-50. 1997
  • Cytomegalovirus retinitis associated with Hodgkin's disease..  16:324-327. 1996
  • Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration..  16:183-189. 1996
  • A numeric index based on spatial frequency for the tortuosity of retinal vessels and its application to plus disease in retinopathy of prematurity..  15:490-500. 1995
  • Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole..  15:53-57. 1995
  • Inferior peripheral iridectomy in patients receiving silicone oil. Rates of postoperative closure and effect on oil position..  15:87-90. 1995
  • Removal of optic disc stalks during diabetic vitrectomy..  15:25-28. 1995
  • Vitrectomy for vitreomacular traction syndrome with macular detachment..  15:192-197. 1995
  • Lightning maculopathy. A case report..  14:169-172. 1994
  • Postoperative fibrin formation and visual outcome after pars plana vitrectomy..  14:225-230. 1994
  • Electrophysiologic monitoring of diabetic retinopathy in pregnancy..  13:99-106. 1993
  • Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3..  13:279-284. 1993
  • The use of silicone oil in uveitis and hypotony..  11:399-404. 1991
  • Management of anterior vitreous traction in proliferative vitreoretinopathy..  9:258-262. 1989
  • Evaluation of choroidal neovascular membranes by Octopus perimetry..  8:24-29. 1988
  • Refractive changes from use of silicone oil in vitreous surgery..  8:20-23. 1988
  • Retinal toxicity of cyanoacrylate tissue adhesive in the rabbit..  8:148-153. 1988
  • A clinicopathologic study of dye laser photocoagulation on primate retina..  7:46-57. 1987
  • Contact lens filter for macular photocoagulation with monochromatic green argon laser..  6:164-168. 1986
  • Silicone oil in vitreoretinal surgery. Part 1: Surgical techniques..  5:189-197. 1985
  • Silicone oil in vitreoretinal surgery. Part 2: Results and complications..  5:198-205. 1985
  • Panretinal photocoagulation and retinal oxygenation..  2:167-175. 1982
  • Vitrectomy, lensectomy, and ocular oxygenation..  2:159-166. 1982
  • Diagnostic and Therapeutic Challenges..  38:849-853. 2018
  • Erratum: Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies (Retina (2008) 28 (298-308)).  31:1236. 2011
  • Erratum: Intraoperative use of handheld spectral domain optical coherence tomography imaging in macular surgery (Retina (2009) 29:10 (1457-1468)).  31:1236. 2011
  • Diagnostic and therapeutic challenges..  24:293-296. 2004
  • Intraoperative Ketorolac and Eye Pain After Vitreoretinal Surgery: A Prospective, Randomized, Placebo-Controlled Study: Reply.  24:183-183. 2004
  • Intraoperative ketorolac and eye pain after vitreoretinal surgery: a prospective, randomized, placebo-controlled study..  24:182-183. 2004
  • Untitled.  23:230-234. 2003
  • Diagnostic and therapeutic challenges..  21:62-64. 2001
  • A new wide-field temporary keratoprosthesis..  13:353-355. 1993
  • MACULAR DEGENERATION: THE LATEST IN CURRENT SURGICAL MANAGEMENT 2006